ARF II MAGDI AWAD SASI 2014 MANAGEMENT OF PRERENAL ARF-----PART TWO REVERSALBE CAUSES OF ARF: 1. Hypovolemia 2. Hypotension 3. Hypercalemia 4. Heart failure 5. Accelerated phase OF hypertension 6. Sepsis 7. Urinary tract infection 8. Urinary tract obstruction 9. Nephrotoxic drug or poison GENERAL LINES OF ARF MANAGEMENT 1. Fluid and electrolyte balance( I/O chart ,patients weight ,RFT and electrolytes) 2. 500 ml fluid and asses the losses (( urine ,faeces ,vomitus ,aspirations ,ventilator , sweating ,increased temperature)) 3. Nutrition ( N/G ,parenteral ): i. Protein 40gm/day (70 gm if H.D.) ii. Potassium restricted diets iii. Fluid and fat for energy iv. Carbohydrate v. Vitamins and trace elements supplement 4. Treatment of complications of ARF 5. Trial of frusemide ,mannitol ,dopamine ,dobutamine infusion after correction of fluid loss ( using CVP line) 6. If no dieresis or ARF complication-----early start of renal replacement therapy 7. Renal replacement therapy: CONTINOUS ARTERIOVENOUS(CAV), CONTINOUS VENOVENOUS(CVV) I. HAEMODIALYSIS OR PERITONEAL DIALYSIS 1 DR MAGDI AWAD SASI
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
ARF II MAGDI AWAD SASI 2014
MANAGEMENT OF PRERENAL ARF-----PART TWO
REVERSALBE CAUSES OF ARF:
1. Hypovolemia2. Hypotension3. Hypercalemia4. Heart failure5. Accelerated phase OF hypertension6. Sepsis7. Urinary tract infection8. Urinary tract obstruction9. Nephrotoxic drug or poison
GENERAL LINES OF ARF MANAGEMENT
1. Fluid and electrolyte balance( I/O chart ,patients weight ,RFT and electrolytes)2. 500 ml fluid and asses the losses (( urine ,faeces ,vomitus ,aspirations ,ventilator ,
2. Decrease cardiac output and myocardial failure----cardiogenic shock
3. Increase in the size of vascular bed---septic shock
4. Intravascular hemolysis
5. Rhabdomyolysis-----release of globins----toxic effect on the kidney
6. Disease of the major renal vessels-----decrease of renal blood:
A. Thrombosis of arteriesB. Occlusive embolus of the aorta or renal arteriesC. Aortic dissecting aneurysm
MANAGEMENT:
1. Compatible history (risk factor for ARF )2. The clinical finding3. Progressive increase in blood urea and creatinine4. Examine for:
Fluid treatment chart (( input and output )) balance.Blood pressure ---hypotension (postural) in shock states.Look signs of dehydration----
Dry mucous membranes, inelastic skin ,decrease its turgor Postural hypotension and taccychardia ( worse in sitting) Collapsed superficial veins ,sunken eyes Cold cyanosed extremities Decrease JVP and CVP, sharp decrease in body weight
Changes in the body weight (( over hydration /dehydration)).
2DR MAGDI AWAD SASI
ARF II MAGDI AWAD SASI 2014
Urine ----------decrease volume Effect of I.V. treatment (rehydration)Diuresis ----prerenal causeFluid over load and danger of pulmonary oedema.
Treatment :
1. Treat the cause.2. Treat hypovolemia:
A. Restore blood pressure( blood , plasma ,fluids)B. Use of inotropic drugs e.g. after correction of blood volume
Body weight x 15 = ----mg of dopamine to be used in 250ccN/S fluid. One drop = 1 micgm 5 –10 drops/min will increase renal perfusion.
c. Best treated by monitoring CVP or PCWP.
3. Treatment of septicemia---avoid nephrotoxic antibiotics
4. Aim of Early treatment---diuresis and improvement of RF
Otherwise, if not, pt is still oliguric ----- treat as ATN.
5. Frusemide and dopamine for pre renal failure is questionable.They are used if unresponsive to fluid challenge.Frusemide:
Don’t give until you are sure that the pt is fully hydrated.Don’t give if aminoglycoside have been usedGive 250mg I.V. over one hour by syringe pump.If the urine output remains ˂ 40 ml/hr over the next hours, give further 500mg I.V. over 2 hours by syringe pump.If the urine output increases ,further doses can be given as required up to maximum daily dose of 2 gm or continuous infusion can be used (30---60mg/hr)
Dopamine :
200---6000microgm/min (has a beneficial effect on renal output.). 400mg in 250ml ( 1600 micrigm/ml) give 1—2 micgm/kg/min (4mg). If dieresis occur , keep dopamine for 24—72hr and taper it.
3DR MAGDI AWAD SASI
ARF II MAGDI AWAD SASI 2014
MANAGEMENT OF RENAL ARF
SUMMARY OF CAUSES:
A. Acute parenchymal disorders:I. Glomerular and vascular diseases:
1. Acute glomerular nephritis (primary or part of systemic disease)2. Vasculitis (including drug induced)3. Malignant HTN4. Arterial or venous occlusion(thrombosis , emboli)5. Microangiopathic haemolysis (TTP,HUS,DIC)
A. Very poor prognosis1. Extensive burns2. BY-pass surgery3. Sepsis following abdominal surgery4. Trauma to abdomen and thorax5. Severe hepatic failure6. Paraquat poisoning7. Criminal abortion associated with clostridal infection8. Any patient requiring ventilation for more than 48hr
B. Good prognosis1. Obstetrical accident without Sepsis2. Trauma to limbs3. Mismatched blood transfusion4. Viral infection( Coxsackie ,influenza ) causing myoglobinuria5. Some nephrotoxin
CLINICAL POINTS TO BE REMMEBERED:1. ATN is the commonest histology in ARF secondary to pre-renal causes or nephrotoxic drugs.2. A urine output ˂25-30ml/hour in adult should be investigated and urgently corrected. If oliguria persists ˃2-3 hour, it may be irreversible3. The simplest screening test for RF in ICU patients are : I. Hourly urine output ( at least 0.5ml/kg/hour) II. Accurate I/O fluid chart III.Daily serum creatinine assessment
Prognosis of ARF : DEPENDS ON
1. CAUSE-----------------Nature and severity of precipitating factor 2. DIAGNOSIS----------Early diagnosis and treatment of ARF complication3. TREATMENT---------Speed and efficiency of ARF treatment.
5DR MAGDI AWAD SASI
ARF II MAGDI AWAD SASI 2014
Clinical presentation: Symptoms and signs of causative disease. Urine----oliguric
Pre renal normal kidney Established ARF CVP ˂ 2CM OF H2O N or high ≥ 12cmResponse to
1) Hydration2) Mannitol or lasix
Dieresis ± Dieresis ±
No effect or risk of pulmonary Edema
URINE volume Specific gravity Sediment Na + Urea Osmolality FE Na%
10) Infection –septicemia and shock due to -----( decrease cellular and humoral immunity)
11) Phases -- oliguric then diuretic
12) Diuretic phase: 7 –10 days ( 4 weeks ) of the onset of S&S Urine increase 3 – 5 l/day persist 4 days Urea is usually increased and creatinine slowly decrease Needs accurate supplement of fluid and electrolytes Few days later----normal chemistry and urine volume and pts can eats normal diet13) PROGNOSIS DEPENDS ON :
1. Speed and efficiency of treatment2. Early recognition and treatment of complication3. Nature and severity of causal disorder e.g.
I. Simple hemorrhageII. Drugs
III. Severe infectionsIV. Multiorgan failure mortality rate 50n--70%
4. Untreated cases----- MR ˃ 90%
7DR MAGDI AWAD SASI
ARF II MAGDI AWAD SASI 2014
GENERAL TREATMENT OF THE OLIGURIC PHASE:
1. Get drug history and alter prescriptions appropriately.
2. Fluid and electrolyte balance (( daily weight ,fluid chart )).3. 500 ml fluid and asses the losses
(( urine ,faeces ,vomitus ,aspirations ,ventilator , sweating ,increased temperature—add 500ml for each increase ˃ 37.5))
4. Skilled nursing care (( mouth , skin )) and senior trained specialists.5. Establish under lying causes and start prompt medical action6. Exclude obstruction of the urinary tract.7. Assess and correct any respiratory or circulatory impairment.8. Nutrition ( NGT, Parenteral)
Protein—40mg/d (( increase to 70gm/d if on dialysis )K restriction dietFat and carbohydrate for energyVitamins supplement
9. Treatment of anemia, hypocalcemia ,DIC ,infections .10.Manage life threatening complications of ARF .
I. HYPERKALEMIAII. SEVERE ACODOSIS
III. SALT AND WATER OVERLOADIV. SEVERE UREMIA
11.Dialysis investigations and accurate I/O .12.Trial of :
I. Furosemide – 1 -2 mg/d and increase to 500-2000mg in 1 hr infusion or ethacryme acid 0.5mg/kg----If urine output is initiated, it can be maintained by lasix 40—80mg4 -8 hourlyDopamine drip (200—600microgm/min)
13.If all fail-----------DIALYSIS .
8DR MAGDI AWAD SASI
ARF II MAGDI AWAD SASI 2014
MANAGEMENT OF POST --RENAL ARF
Obstructive nephropathy may be 2ry to upper or lower urinary tract obstruction.
Early diagnosis and relief of obstruction are essential to prevent renal damage by ultrasound abdomen and urologist consultation.
CLINICAL FEATURES:
1. H/O urinary symptoms—renal colic ,hematuria , difficulty of micturation.2. May be clinically silent and discovered on investigation3. Anuria--------suggestive of obstructive lesion.
Abdominal USS should be done to R/O any obstructive lesion .If it showed pelvic or uretric dilatation ----urgent percutaneous nephrostomy is indicated to avoid need for dialysis treatment.
4. P.V.---palpable CA cervix P.R.----palpable recto-sigmoid junction carcinoma5. Management ---
I. Investigation aiming to diagnose and relief urinary bladder obstructionII. Supportive and palliative treatment may be needed
III. Accurate I.V. fluid treatment after relief of obstruction –postobstuctive dieresis
2. URINE---Na , Urea , Creatinine ,Osmolality . 3. Culture-------blood ,urine ,sputum , wound culture ,tracheostomy. 4. S .complement ,immunological studies –AGN5. Chest x ray , ABD USS , ECG , IVU ( ABDOMEN CAT OR MRI)6. Renal biopsy7. Daily pt weight ---input and out put
9DR MAGDI AWAD SASI
ARF II MAGDI AWAD SASI 2014
TREATMENT OF ARF
1. Emergency measures :I. RX of hyperkalemia
II. Indication of dialysis
2. Determination of ARF cause .
3. General management of the oliguric phase:
I. Fluid and electrolyte balanceII. Nutrition
III. Nursing careIV. InfectionV. Anemia ,DIC, GIT hemorrhage
4. General management of recovery (diuretic ) phase :
Fluid electrolyte , nutrition.
INDICATIONS OF DIALYSIS IN AFR :
URGENT DIALYSIS---
1. Uraemic encephalopathy—impaired conscious level ,coma ,fits2. Fluid overload----- pulmonary edema3. Uraemic Pericarditis4. Uraemic gastritis5. Hyperkalemia(˃ 6.5)---- not responding to medical therapy6. Severe metabolic acidosis( HC03 ≤ 13 or PH ˂ 7.17. Severe hyeruricemia (tumor lysis syndrome8. Oxylate toxicity (ethylene glycol overdose)9. Severe uraemia----200mm0l/d
ROUTINE DIALYSIS :
1. Prevention of severe uremia and its complications ( when conservative TR failed)2. Maintenance of normal fluid ,electrolyte and acid base status ( TR medically failed)3. Space making for parenteral nutrition ,transfusion of blood and blood products 4. Prophylaxis before surgical procedures
10DR MAGDI AWAD SASI
ARF II MAGDI AWAD SASI 2014
TREATMENT OF HYPERKALEMIA ( K ˃ 6mmol/L )
The first thing is to rule out pseudohyperkalemia:
K > 5.5 -6Tall, peaked symmetrical T wavesWide QRSProlong PRDiminished /absent PDepressed STProlonged QTQRS- blends in T ((merge)) – classical sine wave of increase KVentricular fibrillationasystole
11DR MAGDI AWAD SASI
ARF II MAGDI AWAD SASI 2014
I.V. access for:
Ca gluconate (10ml 10%)diluted over 10 minutes --AIM --protect heartGlucose 50ml 50%--with regular insulin 10 units , may be repeated.Na HCO3 8.4% 50cc for each 0.1 ▼ blood PH to correct metabolic acidosisCa or Na resonium (30mg) orally or rectallyB-agonist (IV /inhaler)-10-20mg albuterol decrease K in half hour for 2 hours
Once k ˂6mmol/l---dextrose 20% (30ml/hr) to prevent rebound hyperkalemiaDialysis---- definitive treatment if there is ECG changes
Summary of hyperkalemia TR:
TREATMENT OF BLOOD PRESSURE
Hypotension(shock)-----best under C.V.P.
1. I.V. fluids ,blood2. Dopamine ---IV drip
Hypertension:-
1. Ca channel blockers ,clonidine ,prazosine2. IV Na nitroprusside (may be needed in some cases)3. Dialysis TO BE CONTINUED